Zusammenfassung
Folgende Muskelrelaxanzien werden nicht bzw nicht nennenswert hepatisch metabolisiert
-
1.
Rocuronium
-
2.
Doxacurium
-
3.
Mivacurium
-
4.
Pipecuronium
-
5.
Succinylcholin
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Atherton DP, Hunter JM (1999) Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Clin Pharmacokinet 36: 169–189
Caldwell JE (1989) Muscle relaxants and renal failure. In: Rupp SM (ed) Problems in Anesthesia, Vol 3: Neuromuscular Relaxants. Lippincott, Philadelphia, pp 489–499
Hunter JM (1989) Muscle relaxants. Curr Anaesth Critical Care 1: 38–46
Kopman AF (1997) Review of new and available muscle relaxants. ASA Annual Refresher Course Lectures, San Diego, # 212
Savarese JJ (1999) Neuromuscular blocking drugs: update your clinical practice. ASA Annual Refresher Course Lectures, Dallas, # 164
Sladen RN (1988) Perioperative management of the patient with renal failure. ASA Annual Refresher Course Lectures, San Francisco, # 172
Tonnesen AS (1989) Anesthesia for the patient with renal failure. ASA Annual Refresher Course Lectures, New Orleans, # 256
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Petroianu, G., Osswald, P.M. (2000). Muskelrelaxanzien (2). In: Anästhesie in Frage und Antwort. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05715-5_47
Download citation
DOI: https://doi.org/10.1007/978-3-662-05715-5_47
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-66276-1
Online ISBN: 978-3-662-05715-5
eBook Packages: Springer Book Archive